There has been a remarkable temporal evolution in the treatment of ITP, from splenectomy and B-cell depletion therapy at the beginning of the 21st century to thrombopoietic agents and TPO-RAs in the last decade. Here, TPO is linked to autoimmune thrombocytopenic purpura.